The European Commission has granted marketing authorisation for mRESVIA®, a respiratory syncytial virus (RSV) vaccine developed by Moderna, Inc. (NASDAQ). The vaccine is designed to protect…
Discover precise insights into the intersections of health, society, and culture in the UK at Social Equality. Your reliable source for clear and comprehensive coverage.
Company
© 2024 Social Equality – socialequality.org.uk | All Rights Reserved.